Document Detail


Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004).
MedLine Citation:
PMID:  19178669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Feline large granular lymphocyte (LGL) lymphoma is an uncommon, morphologically distinct variant of feline lymphoma. Limited information exists in the literature regarding pathological and immunohistochemical descriptions, clinical findings, treatment and survival times. The purpose of this study was to describe clinical features, treatment and outcome in feline LGL lymphoma. Medical records of 45 cats with LGL lymphoma were retrospectively evaluated. Decreased appetite/anorexia, weight loss, lethargy and vomiting were the most commonly reported clinical signs. All cats tested for feline leukaemia virus and feline immunodeficiency virus infection were negative. The mesenteric lymph nodes and small intestine were the most commonly affected organs. One complete response and six partial responses were noted in the 23 cats that received chemotherapy as their initial treatment. Median survival time for cats that were treated was 57 days. Based on these results, feline LGL lymphoma appears to be minimally responsive to chemotherapy and is associated with a grave prognosis.
Authors:
E L Krick; L Little; R Patel; F S Shofer; K Sorenmo; C A Clifford; J L Baez
Related Documents :
8445789 - Seroprevalence of infectious disease agents in free-ranging florida panthers (felis con...
9375019 - Infection of cats by injection with dna of a feline immunodeficiency virus molecular cl...
7514859 - Expression of reverse transcriptase from feline immunodeficiency virus in escherichia c...
1659469 - The promoter of human t-cell leukemia virus type-i is repressed by the immediate-early ...
16998729 - Human t-cell lymphotropic virus type i (htlv-i) confirmed by pcr-southern blot and sequ...
16276549 - The human t-cell leukemia virus type 1 (htlv-1): new insights into the clinical aspects...
7474139 - An active-site mutation in the human immunodeficiency virus type 1 proteinase (pr) caus...
19726609 - A full-length infectious clone of beet soil-borne virus indicates the dispensability of...
12393149 - Construction of yellow fever-influenza a chimeric virus particles.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Veterinary and comparative oncology     Volume:  6     ISSN:  1476-5829     ISO Abbreviation:  Vet Comp Oncol     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2009-01-30     Completed Date:  2009-03-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101185242     Medline TA:  Vet Comp Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  102-10     Citation Subset:  IM    
Affiliation:
Department of Clinical Studies, Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA. ekrick@vet.upenn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / therapeutic use*
Cat Diseases / drug therapy,  pathology*
Cats
Female
Immunohistochemistry / veterinary
Lymphoma / drug therapy,  pathology,  veterinary*
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy,  pathology,  veterinary*
Prognosis
Retrospective Studies
Survival Analysis
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
Next Document:  Dose-escalating vinblastine for the treatment of canine mast cell tumour.